VIDEO: Trudhesa nasal spray effective in treating migraines
Click Here to Manage Email Alerts
SEATTLE — Trudhesa was effective in treating migraines of varying severity, a speaker said at the 2022 American Academy of Neurology annual meeting.
“Trudhesa (dihydroergotamine mesylate, Impel NeuroPharma)] worked when patients took it for their migraine attacks, even when their migraine attacks were severe,” Sheena K. Aurora, MD, a neurologist and vice president of medical affairs at Impel NeuroPharma, said.
Editor's Note: This article was revised on April 20, 2022, in order to better accurately describe the affects of Trudhesa.